RAY WANG to Cross-Over Studies
This is a "connection" page, showing publications RAY WANG has written about Cross-Over Studies.
Connection Strength
0.143
-
The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII. Mol Genet Metab. 2020 03; 129(3):219-227.
Score: 0.143